BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 9878219)

  • 1. Breakdown of the inner and outer blood retinal barrier in streptozotocin-induced diabetes.
    Do carmo A; Ramos P; Reis A; Proença R; Cunha-vaz JG
    Exp Eye Res; 1998 Nov; 67(5):569-75. PubMed ID: 9878219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Microscopic quantification of fluorescein distribution in retinas of normal and diabetic rats].
    Proença D; Proença RD; Cunha-Vaz JG
    J Fr Ophtalmol; 1990; 13(10):489-91. PubMed ID: 2081838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of vitreoretinal VEGF elevation and blood-retinal barrier breakdown in streptozotocin-induced diabetic rats by brimonidine.
    Kusari J; Zhou SX; Padillo E; Clarke KG; Gil DW
    Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):1044-51. PubMed ID: 19710406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas.
    Murata T; Nakagawa K; Khalil A; Ishibashi T; Inomata H; Sueishi K
    Lab Invest; 1996 Apr; 74(4):819-25. PubMed ID: 8606491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcein fluorophotometry in streptozocin-induced diabetic rats.
    Golshani MR; Khoobehi B; Peyman GA; Aras C
    Ophthalmic Surg; 1994 Aug; 25(8):526-31. PubMed ID: 7970535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Permeability of the blood-retinal barrier and the blood-aqueous barrier in type I diabetes without diabetic retinopathy: simultaneous evaluation with fluorophotometry.
    Schalnus R; Ohrloff C; Jungmann E; Maass K; Rinke S; Wagner A
    Ger J Ophthalmol; 1993 Aug; 2(4-5):202-6. PubMed ID: 8220099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of memantine on neuroretinal function and retinal vascular changes of streptozotocin-induced diabetic rats.
    Kusari J; Zhou S; Padillo E; Clarke KG; Gil DW
    Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5152-9. PubMed ID: 17962468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of cyclosporin-A on the blood--retinal barrier permeability in streptozotocin-induced diabetes.
    Carmo A; Cunha-Vaz JG; Carvalho AP; Lopes MC
    Mediators Inflamm; 2000; 9(5):243-8. PubMed ID: 11200365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retina.
    Tamura H; Miyamoto K; Kiryu J; Miyahara S; Katsuta H; Hirose F; Musashi K; Yoshimura N
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1440-4. PubMed ID: 15790913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative MR imaging study of intravitreal sustained release of VEGF in rabbits.
    Alikacem N; Yoshizawa T; Nelson KD; Wilson CA
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1561-9. PubMed ID: 10798677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of permeability in blood-retinal barrier.
    Kojima M; Yoshida A; Ishiko S; Tanaka K
    Hokkaido Igaku Zasshi; 1990 Jul; 65(4):419-27. PubMed ID: 2227794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered expression of genes related to blood-retina barrier disruption in streptozotocin-induced diabetes.
    Klaassen I; Hughes JM; Vogels IM; Schalkwijk CG; Van Noorden CJ; Schlingemann RO
    Exp Eye Res; 2009 Jun; 89(1):4-15. PubMed ID: 19284967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of acetazolamide on passive and active transport of fluorescein across the normal BRB.
    Moldow B; Sander B; Larsen M; Lund-Andersen H
    Invest Ophthalmol Vis Sci; 1999 Jul; 40(8):1770-5. PubMed ID: 10393047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrastructural localization of blood-retinal barrier breakdown in diabetic and galactosemic rats.
    Vinores SA; McGehee R; Lee A; Gadegbeku C; Campochiaro PA
    J Histochem Cytochem; 1990 Sep; 38(9):1341-52. PubMed ID: 2117624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetic macular edema: passive and active transport of fluorescein through the blood-retina barrier.
    Sander B; Larsen M; Moldow B; Lund-Andersen H
    Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):433-8. PubMed ID: 11157879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood-retinal barriers in health and disease.
    Cunha-Vaz JG
    Trans Ophthalmol Soc U K (1962); 1980 Sep; 100(3):337-40. PubMed ID: 6946626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihistamines reduce blood-retinal barrier permeability in type I (insulin-dependent) diabetic patients with nonproliferative retinopathy. A pilot study.
    Gardner TW; Eller AW; Friberg TR; D'Antonio JA; Hollis TM
    Retina; 1995; 15(2):134-40. PubMed ID: 7624601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative assessment of the integrity of the blood-retinal barrier in mice.
    Derevjanik NL; Vinores SA; Xiao WH; Mori K; Turon T; Hudish T; Dong S; Campochiaro PA
    Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2462-7. PubMed ID: 12091451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes. The Penn State Retina Research Group.
    Barber AJ; Antonetti DA; Gardner TW
    Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3561-8. PubMed ID: 11006253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy.
    Leal EC; Manivannan A; Hosoya K; Terasaki T; Cunha-Vaz J; Ambrósio AF; Forrester JV
    Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5257-65. PubMed ID: 17962481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.